Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China · Delayed Price · Currency is CNY 28.08
-0.75 (-2.60%)
Apr 9, 2026, 4:00 PM EDT
SHE:301089 Revenue
In the year 2025, Tuoxin Pharmaceutical Group had annual revenue of 378.34M CNY, down -10.28%. Tuoxin Pharmaceutical Group had revenue of 106.79M in the quarter ending December 31, 2025, with 11.31% growth.
Revenue
378.34M
Revenue Growth
-10.28%
P/S Ratio
9.39
Revenue / Employee
243.94K
Employees
1,551
Market Cap
3.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 378.34M | -43.35M | -10.28% |
| Dec 31, 2024 | 421.69M | -413.82M | -49.53% |
| Dec 31, 2023 | 835.51M | 50.79M | 6.47% |
| Jan 1, 2023 | 784.72M | 282.24M | 56.17% |
| Jan 1, 2022 | 502.48M | -25.46M | -4.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Well Pharmaceutical Group | 1.31B |
| Huaren Pharmaceutical | 1.26B |
| Shaanxi Panlong Pharmaceutical Group Limited By Share | 1.10B |
| Hunan Hansen Pharmaceutical | 1.05B |
| Anhui Sunhere Pharmaceutical Excipients | 934.72M |
| Harbin Medisan Pharmaceutical | 874.60M |
| Jiangxi Synergy Pharmaceutical | 825.20M |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |